Abstract
A new mouse model of Alzheimer's disease suggests that an intracellular domain of amyloid precursor protein—and not β-amyloid—causes the disease. The findings could provide additional mechanistic validation for companies developing molecules that block the production of the intracellular APP domain, including BACE1 and γ-secretase inhibitors.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
